Status:
RECRUITING
CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome
Lead Sponsor:
Meyer Children's Hospital IRCCS
Conditions:
Camptodactyly
Arthropathy
Eligibility:
All Genders
Up to 18 years
Brief Summary
CACP syndrome is a rare autosomal recessive disorder characterized by the triad of camptodactyly, non-inflammatory arthropathy with synovial hyperplasia, and coxa vara. Occasionally, non-inflammatory ...
Eligibility Criteria
Inclusion Criteria:
- Patients with clinical diagnosis and genetic confirmation of CACP syndrome.
- Patients diagnosed during pediatric age (<18 years).
- Time frame: Patients diagnosed with CACP between January 2005 and January 1, 2026.
- Informed consent obtained from parents or legal guardians.
Exclusion Criteria:
- Patients without genetic confirmation of the diagnosis.
- Lack of informed consent from parents or legal guardians.
- Patients diagnosed before January 1, 2005, or after January 1, 2026.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2038
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07468461
Start Date
August 1 2025
End Date
January 1 2038
Last Update
March 16 2026
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Pediatrico Giovanni XXIII
Bari, Italy
2
Rheumatology Unit, Meyer Children's Hospital
Florence, Italy
3
IRCCS Istituto Giannina Gaslini,
Genova, Italy
4
ASST Fatebenefratelli
Milan, Italy